Warren Averett Asset Management »

Immunitybio shares owned by Warren Averett Asset Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Warren Averett Asset Management from 13F filings

Historical chart of Warren Averett Asset Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Warren Averett Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Warren Averett Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $110k 45k 2.46
2025-06-30 $92k 35k 2.64
2025-03-31 $60k 20k 3.01
2024-12-31 $38k 15k 2.56

More positions owned by Warren Averett Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
Apple (AAPL)
Vanguard Specialized Funds Div App Etf (VIG)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust Portfolio Intrmd (SPIB)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Rus 1000 Etf (IWB)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
J P Morgan Exchange Traded F Income Etf (JPIE)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Warren Averett Asset Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
Jane Street
State Street Corporation
Geode Capital Management
Heights Capital Management
Woodline Partners
Susquehanna International
AlphaCore Capital
Morgan Stanley
Two Sigma Investments
Tang Capital Management
Charles Schwab Investment Management
Citadel Advisors
Northern Trust

View all funds holding Immunitybio